Zharkovskiĭ A M, Beliakov A V
Farmakol Toksikol. 1983 Sep-Oct;46(5):22-4.
It has been shown in experiments on male mice that prolonged administration (for 20 days) of haloperidol in doses of 0.1, 1.0, 5.0 and 10.00 mg/kg produced an increase in the tolerance to thecataleptogenic effect at the end of administration and a rise in 3H-spiroperidole binding with striatum membranes on the 5th day after discontinuation of the neuroleptic, which attests to an increase in the sensitivity of dopamine receptors. Variation of haloperidol dose every other three days during 20 days of drug administration (1.0--0.1 ... 1.0 mg/kg and 1.0--10.00 ... 1.0 mg/kg) eliminated the manifestations of tolerance and hypersensitivity of dopamine receptors. It is assumed that variation of the neuroleptic dose during prolonged administration prevents the development of extrapyramidal disorders of the hyperkinetic type.
在雄性小鼠实验中已表明,以0.1、1.0、5.0和10.00毫克/千克的剂量长期给予氟哌啶醇(持续20天),在给药结束时对致僵作用的耐受性增加,且在停用抗精神病药物后的第5天,纹状体膜与3H-螺哌利多的结合增加,这证明多巴胺受体的敏感性增加。在给药的20天期间,每隔三天改变一次氟哌啶醇剂量(1.0--0.1...1.0毫克/千克和1.0--10.00...1.0毫克/千克)可消除多巴胺受体耐受性和超敏反应的表现。据推测,长期给药期间抗精神病药物剂量的改变可预防运动亢进型锥体外系疾病的发生。